BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, July 23, 2026
Breaking News: Best of BioWorld Science: Q2
Breaking News: Science fiction realized: BCI tech is here
Breaking News: Science fiction realized: BCI tech is here
Home
»
Topics
» BioWorld Science, Endocrine/metabolic
BioWorld Science, Endocrine/metabolic
RSS
New GPR119 receptor agonists described by Nippon Chemiphar
July 27, 2011
Takeda resubmits NDAs for two diabetes therapies
July 26, 2011
Raptor Pharmaceuticals reports phase III results on RP-103
July 26, 2011
Bionovo completes animal toxicology studies of Menerba
July 26, 2011
Array BioPharma patents new CSF-1-R inhibitors
July 26, 2011
CHMP makes recommendations following review of pioglitazone-containing medicines
July 25, 2011
Potent PTP-1B-targeted antisense therapy enters phase I trial in type 2 diabetes
July 25, 2011
Mochida Pharmaceutical prepares new free fatty acid FFA1 receptor agonists
July 25, 2011
Manhattan Pharmaceuticals and FDA reach agreement on SPA for phase III AST-726 trial
July 22, 2011
Galapagos small-molecule SARM enters proof-of-mechanism phase I trial
July 20, 2011
Previous
1
2
…
621
622
623
624
625
626
627
628
629
…
1800
1801
Next
RSS